Habiba Atta

Bispecific programs differ by practice size, but shared core components can guide adaptation, experts said at a webinar for the Bispecifics Network.

Bipolar disorder often goes undiagnosed for years, and clinicians need to separate mood episodes from normal emotions and keep patients on treatment.

Pharmacists are moving beyond order verification into patient education, adverse effect mitigation, and parts of toxicity triage in bispecific care.

Bipolar disorder can take 5 to 10 years to diagnose, and missing it can harm patients’ jobs, relationships, finances, and health.

Initial frontal fibrosing alopecia treatment was largely similar in Black and White patients, though tetracycline use was higher in Black patients.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Alternating platelet-rich plasma and intralesional corticosteroids was well tolerated in a pediatric Asian patient with severe alopecia areata.

A review finds vertigo is an underrecognized sign of multiple sclerosis (MS) relapse and that the HINTS exam cannot distinguish an MS attack from stroke.

University of Virginia Health is tracking efgartigimod durability in generalized myasthenia gravis and how pharmacists help patients get past barriers.

Clinicians at CHEST 2026 say costs and outcomes are shaped well beyond the ICU, from surgical choices to discharge planning and end-of-life talks.

A systematic review found vitamin D did not consistently reduce MS relapse rates, though some studies reported lower MRI lesion activity.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Samantha Pettigrew, MD, explains blood clot risk factors, treatment, and return to play in the wake of the news of Jalen Hurts season-ending diagnosis.

Declining serum GFAP during MS treatment was tied to lower PIRA risk, supporting its use as a biomarker for treatment response.

EMR inboxes and insurance peer-to-peer calls are pulling clinicians away from patients, a growing concern reflected across CHEST 2026.

A COPD discharge checklist and navigator improved readmissions without lengthening hospital stays or increasing emergency department revisits.

Early goals-of-care talks, ethics consults, and upstream planning can help ICU teams deliver care that matches what patients actually want.

Charge nurse–led multidisciplinary rounds caught ICU lines and catheters due for removal that academic teaching rounds often missed, said Pooja Roy, MD.

Limited access to care means safety-net ICUs see advanced disease and poorer outcomes, while bias and social media add new challenges to care.

Pulmonologists play a key role in comprehensive biomarker testing, helping more patients with lung cancer access precise targeted therapies.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

A historical review traces Sjögren disease from its early descriptions to the use of salivary gland ultrasound in diagnosis.

Stigma, years-long diagnostic delays, and limited follow-up after a crisis remain hurdles for people with serious mental illness, experts say.

Eliot F. Battle, MD, says safe laser treatment in skin of color depends on age, genetics, and inflammation, not Fitzpatrick skin type alone.

Labial gland biopsy may support diagnosis of neurologic Sjögren disease, especially when antibody tests are negative or inconclusive.

Rosacea is likely missed, not rare, in skin of color, as low suspicion and hard-to-see redness delay diagnosis, said Hilary Baldwin, MD.

Hidradenitis suppurativa diagnosis often takes 7 to 10 years, and patients with skin of color often present with tunnels and scarring already in place.

Older adults on Medicare report the best access to care among 10 countries but more cost-related problems and higher out-of-pocket spending.

Patients with Sjögren disease diagnosed over a year after symptom onset had 2.3 times the odds of moderate or greater disease activity, a US survey found.

An estimated 44,052 sports eye injuries were treated in 2025 and 1262 pickleball eye injuries in 2024; 99% of lawnmower eye injuries were at home.